<unk>  is a dipeptidyl peptidase-4 inhibitor that is FDA approved for the {{{indicationType}}} of type 2 diabetes mellitus.   Common adverse reactions include hypoglycemia, headache, nasopharyngitis, and upper respiratory infection.
Sitagliptin
Linagliptin
Vildagliptin
Saxagliptin
Liraglutide
Exenatide
Pioglitazone
Canagliflozin